Moore JP - Search Results

1

Evaluating the immunogenicity of a disulfide-stabilized, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1.

Beddows S, Schülke N, Kirschner M, Barnes K, Franti M, Michael E, Ketas T, Sanders RW, Maddon PJ, Olson WC, Moore JP. Beddows S, et al. Among authors: moore jp. J Virol. 2005 Jul;79(14):8812-27. doi: 10.1128/JVI.79.14.8812-8827.2005. J Virol. 2005. PMID: 15994775 Free PMC article.

2

CPF-DD is an inhibitor of infection by human immunodeficiency virus and other enveloped viruses in vitro.

Moore JP, Simpson G, McKeating JA, Burakoff SJ, Schreiber SL, Weiss RA. Moore JP, et al. Virology. 1992 Jun;188(2):537-44. doi: 10.1016/0042-6822(92)90508-m. Virology. 1992. PMID: 1316672

3

A monoclonal antibody to CD4 domain 2 blocks soluble CD4-induced conformational changes in the envelope glycoproteins of human immunodeficiency virus type 1 (HIV-1) and HIV-1 infection of CD4+ cells.

Moore JP, Sattentau QJ, Klasse PJ, Burkly LC. Moore JP, et al. J Virol. 1992 Aug;66(8):4784-93. doi: 10.1128/JVI.66.8.4784-4793.1992. J Virol. 1992. PMID: 1378510 Free PMC article.

4

Factors underlying spontaneous inactivation and susceptibility to neutralization of human immunodeficiency virus.

Layne SP, Merges MJ, Dembo M, Spouge JL, Conley SR, Moore JP, Raina JL, Renz H, Gelderblom HR, Nara PL. Layne SP, et al. Among authors: moore jp. Virology. 1992 Aug;189(2):695-714. doi: 10.1016/0042-6822(92)90593-e. Virology. 1992. PMID: 1386485

5

Complementation of human immunodeficiency virus glycoprotein mutations in trans.

Morikawa Y, Moore JP, Fenouillet E, Jones IM. Morikawa Y, et al. Among authors: moore jp. J Gen Virol. 1992 Aug;73 ( Pt 8):1907-13. doi: 10.1099/0022-1317-73-8-1907. J Gen Virol. 1992. PMID: 1645136

6

Rat monoclonal antibodies to nonoverlapping epitopes of human immunodeficiency virus type 1 gp120 block CD4 binding in vitro.

Cordell J, Moore JP, Dean CJ, Klasse PJ, Weiss RA, McKeating JA. Cordell J, et al. Among authors: moore jp. Virology. 1991 Nov;185(1):72-9. doi: 10.1016/0042-6822(91)90755-z. Virology. 1991. PMID: 1718090

7

Virions of primary human immunodeficiency virus type 1 isolates resistant to soluble CD4 (sCD4) neutralization differ in sCD4 binding and glycoprotein gp120 retention from sCD4-sensitive isolates.

Moore JP, McKeating JA, Huang YX, Ashkenazi A, Ho DD. Moore JP, et al. J Virol. 1992 Jan;66(1):235-43. doi: 10.1128/JVI.66.1.235-243.1992. J Virol. 1992. PMID: 1727487 Free PMC article.

8

Differential loss of envelope glycoprotein gp120 from virions of human immunodeficiency virus type 1 isolates: effects on infectivity and neutralization.

McKeating JA, McKnight A, Moore JP. McKeating JA, et al. Among authors: moore jp. J Virol. 1991 Feb;65(2):852-60. doi: 10.1128/JVI.65.2.852-860.1991. J Virol. 1991. PMID: 1898972 Free PMC article.

9

Induction of high-titer neutralizing antibodies, using hybrid human immunodeficiency virus V3-Ty viruslike particles in a clinically relevant adjuvant.

Griffiths JC, Berrie EL, Holdsworth LN, Moore JP, Harris SJ, Senior JM, Kingsman SM, Kingsman AJ, Adams SE. Griffiths JC, et al. Among authors: moore jp. J Virol. 1991 Jan;65(1):450-6. doi: 10.1128/JVI.65.1.450-456.1991. J Virol. 1991. PMID: 1985208 Free PMC article.

10

Direct measurement of soluble CD4 binding to human immunodeficiency virus type 1 virions: gp120 dissociation and its implications for virus-cell binding and fusion reactions and their neutralization by soluble CD4.

Moore JP, McKeating JA, Norton WA, Sattentau QJ. Moore JP, et al. J Virol. 1991 Mar;65(3):1133-40. doi: 10.1128/JVI.65.3.1133-1140.1991. J Virol. 1991. PMID: 1995942 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

769 results

Search Page

Filters